Episurf Medical hires Patrick Jamnik to head US business
Episurf Medical (NASDAQ: EPIS B) today announces its hiring of Patrick Jamnik as President of Episurf Medical Inc. In this newly created role, Mr Jamnik will be responsible for all US activities as Episurf Medical continues its international expansion. A veteran of both Stryker and Zimmer-Biomet, Mr Jamnik has extensive experience spanning over 16 years building and commercialising businesses across multiple orthopaedic disciplines in both Europe and the US.
In a previous role, Mr Jamnik served as Global Marketing Director at Stanmore Implants, a venture-backed United Kingdom-based company providing patient-specific implant solutions to orthopaedic oncology surgeons. During his time at Stanmore, Mr Jamnik played a central role in establishing, commercialising, and growing its US business, contributing to its eventual acquisition by Stryker. Mr Jamnik also spent over eight years in sales roles at Zimmer Biomet, where he consistently grew territory market shares successfully. Most recently, he served as Vice President of Business Development & Strategic Initiatives at InspireMD, an Israeli-based company operating within the field of vascular stenting. He received both a BA and MBA from the University of Wisconsin-Madison.
“As the orthopaedic industry continues to evolve, the demands facing implant companies continue to increase,” states Mr Jamnik. “Patients are demanding more personalised solutions to their specific condition, surgeons are demanding more meaningful industry collaboration, and regulators are demanding more thorough clinical data. Episurf sits perfectly at the nexus of these changes. Over the past few years, I have watched as Episurf has taken the central element to any young medical device business – an unmet clinical need – and laid on top of it a series of foundational pieces – robust clinical data, an innovative product pipeline, and a strong investor base. I am thrilled to be joining the company at such an exciting and important time and look forward to working with our customers to help ensure that no patient cohort continues to go underserved.”
“It is with great pleasure that we welcome Patrick to Episurf. Patrick has been in the orthopaedic industry since his summers in college and knows the business inside and out. But more importantly, he has demonstrated that he is a leader who can execute strategic initiatives successfully. He has worked for smaller companies as well as large market leaders, and his experience fits our vision very well. We have an exciting pipeline for the US market, including clinical trials and product launches, and Patrick will play an important role in driving these initiatives”, says Pål Ryfors, CEO Episurf Medical.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CEST on 23 August 2021.
Tags:
